Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin. 2021;1–41.
   Web of Science ®Google Scholar
• Arbyn M, Xu L, Simoens C, et al. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors [J]. Cochrane Database Syst Rev. 2018;5(5):Cd009069.
   PubMedGoogle Scholar
• Cohen PA, Jhingran A, Oaknin A, et al. Cervical cancer [J]. Lancet. 2019;393(10167):169–182.
   PubMed Web of Science ®Google Scholar
• Kapranov P, Cawley SE, Drenkow J, et al. Large-scale transcriptional activity in chromosomes 21 and 22 [J]. Science. 2002;296(5569):916–919.
   PubMed Web of Science ®Google Scholar
• Esteller M. Non-coding RNAs in human disease [J]. Nat Rev Genet. 2011;12(12):861–874.
   PubMed Web of Science ®Google Scholar
• Garzon R, Calin GA, Croce CM. MicroRNAs in cancer [J]. Annu Rev Med. 2009;60:167–179.
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer [J]. Nat Med. 2015;21(11):1253–1261.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Veno MT, et al. Circular RNAs in cancer: opportunities and challenges in the field [J]. Oncogene. 2018;37(5):555–565.
   PubMed Web of Science ®Google Scholar
• Tornesello ML, Faraonio R, Buonaguro L, et al. The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer [J]. Front Oncol. 2020;10(150):1-13.
   Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? [J]. Cell. 2011;146(3):353–358.
   PubMed Web of Science ®Google Scholar
• Fan CN, Ma L, Liu N. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer [J]. J Transl Med. 2018;16(1):264.
   PubMed Web of Science ®Google Scholar
• Kong X, Hu S, Yuan Y, et al. Analysis of lncRNA, miRNA and mRNA-associated ceRNA networks and identification of potential drug targets for drug-resistant non-small cell lung cancer [J]. J Cancer. 2020;11(11):3357–3368.
   PubMed Web of Science ®Google Scholar
• Liu H, Deng H, Zhao Y, et al. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling [J]. J Exp Clin Cancer Res. 2018;37(1):279.
   PubMedGoogle Scholar
• Huang Z, Lei W, Hu HB, et al. H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17 [J]. J Cell Physiol. 2018;233(10):6768–6776.
   PubMed Web of Science ®Google Scholar
• Yang XZ, Cheng TT, He QJ, et al. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway [J]. Mol Cancer. 2018;17(1):126.
   PubMed Web of Science ®Google Scholar
• Hsu SD, Lin FM, Wu WY, et al. miRTarBase: a database curates experimentally validated microRNA-target interactions [J]. Nucleic Acids Res. 2011;39( Database issue):D163–9.
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
   PubMed Web of Science ®Google Scholar
• Bolstad BM, Irizarry RA, Astrand M, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003;19:185–193.
   PubMed Web of Science ®Google Scholar
• Maag JLV. Gganatogram: an R package for modular visualisation of anatograms and tissues based on ggplot2 [J]. F1000Res. 2018;7(1576):1-16.
   PubMedGoogle Scholar
• Szklarczyk D, Franceschini A, Kuhn M, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored [J]. Nucleic Acids Res. 2011;39( Database issue):D561–8.
   PubMed Web of Science ®Google Scholar
• Wang W, Lou W, Ding B, et al. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer [J]. Aging (Albany NY). 2019;11(9):2610–2627.
   PubMedGoogle Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;07(3):45.
   Google Scholar
• Nagy A, Lánczky A, Menyhárt O, et al. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018;8:9227.
   PubMed Web of Science ®Google Scholar
• Fan Y, Siklenka K, Arora SK, et al. miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis [J]. Nucleic Acids Res. 2016;44(W1):W135–41.
   PubMed Web of Science ®Google Scholar
• Fan Y, Xia J. miRNet-functional analysis and visual exploration of miRNA-target interactions in a network context [J]. Methods Mol Biol. 2018;1819:215–233.
   PubMedGoogle Scholar
• J H L, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data [J]. Nucleic Acids Res. 2014;42( Database issue):D92–7.
   PubMed Web of Science ®Google Scholar
• J H Y, J H L, Shao P, et al. starBase: a database for exploring microRNA-mRNA interaction maps from argonaute CLIP-Seq and degradome-Seq data [J]. Nucleic Acids Res. 2011;39( Database issue):D202–9.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling in growth control and disease [J]. Cell. 2012;149(2):274–293.
   PubMed Web of Science ®Google Scholar
• Qian X, Zhao J, Yeung PY, et al. Revealing lncRNA structures and interactions by sequencing-based approaches [J]. Trends Biochem Sci. 2019;44(1):33–52.
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy [J]. Nat Rev Genet. 2016;17(5):272–283.
   PubMed Web of Science ®Google Scholar
• Moore DH. Cervical cancer [J]. Obstet Gynecol. 2006;107(5):1152–1161.
   PubMed Web of Science ®Google Scholar
• Waggoner SE. Cervical cancer [J]. Lancet. 2003;361(9376):2217–2225.
   PubMed Web of Science ®Google Scholar
• Gougousis S, Mouchtaropoulou E, Besli I, et al. HPV-related oropharyngeal cancer and biomarkers based on epigenetics and microbiome profile. Front Cell Dev Biol. 2021;14(8):625330.
   Google Scholar
• Park S-H, Kim M, Lee S, et al. Therapeutic potential of natural products in treatment of cervical cancer: a review. Nutrients. 2021;13(1):154.
   PubMed Web of Science ®Google Scholar
• Tornesello ML, Faraonio R, Buonaguro L, et al. The role of microRNAs, long non-coding RNAs, and circular RNAs in cervical cancer. Front Oncol. 2020 Feb 20;10:150.
   PubMed Web of Science ®Google Scholar
• Galvão MLTC, Coimbra EC. Long noncoding RNAs (lncRNAs) in cervical carcinogenesis: new molecular targets, current prospects. Crit Rev Oncol Hematol. 2020 Dec;156:1-11.
   Web of Science ®Google Scholar
• Rui X, Xu Y, Jiang X, et al. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis [J]. Cell Death Dis. 2018;9(12):1175.
   PubMedGoogle Scholar
• Tang Q, Chen Z, Zhao L, et al. Circular RNA hsa_circ_0000515 acts as a miR-326 sponge to promote cervical cancer progression through up-regulation of ELK1 [J]. Aging (Albany NY). 2019;11(22):9982–9999.
   PubMedGoogle Scholar
• Jacquemet G, Hamidi H, Ivaska J. Filopodia in cell adhesion, 3D migration and cancer cell invasion [J]. Curr Opin Cell Biol. 2015;36:23–31.
   PubMed Web of Science ®Google Scholar
• Maziveyi M, Alahari SK. Cell matrix adhesions in cancer: the proteins that form the glue [J]. Oncotarget. 2017;8(29):48471–48487.
   PubMedGoogle Scholar
• Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets [J]. Angiogenesis. 2017;20(4):409–426.
   PubMed Web of Science ®Google Scholar
• Powell E, Piwnica-Worms D, Piwnica-Worms H. Contribution of p53 to metastasis [J]. Cancer Discov. 2014;4(4):405–414.
   PubMed Web of Science ®Google Scholar
• Chang WH, Lai AG. The pan-cancer mutational landscape of the PPAR pathway reveals universal patterns of dysregulated metabolism and interactions with tumor immunity and hypoxia [J]. Ann N Y Acad Sci. 2019;1448(1):65–82.
   PubMed Web of Science ®Google Scholar
• Dustin D, Gu G, Fuqua SAW. ESR1 mutations in breast cancer [J]. Cancer. 2019;125(21):3714–3728.
   PubMed Web of Science ®Google Scholar
• Currie CE, Mora-Santos M, Smith CA, et al. Bub1 is not essential for the checkpoint response to unattached kinetochores in diploid human cells [J]. Curr Biol. 2018;28(17):R929–r30.
   PubMed Web of Science ®Google Scholar
• Mur P, De Voer RM, Olivera-Salguero R, et al. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are infrequent in familial colorectal cancer and polyposis [J]. Mol Cancer. 2018;17(1):23.
   PubMedGoogle Scholar